Butterfly Network: The Cost of Underdiagnosis: Managing CHF with Handheld POCUS
Saturday, October 1
12:00 p.m.–12:15 p.m.
Location: Learning Lab Stage
Speaker: Dr. Peter Weimersheimer, Vice President, Clinical Implementation
Learning Lab Information
Congestive heart failure (CHF) is a chronic progressive disease affecting 5.3 million people annually, leading to 12 to 15 million office visits and 6.5 million hospital inpatient days each year. An acute diagnosis of CHF has a 40% one-year mortality and 50% rate of annual hospitalization. Early diagnosis and aggressive management of CHF are associated with lower mortality rates, lower hospital admissions, and a better quality of life. The clinical dilemma for practitioners is that neither the acute diagnosis of patients with CHF nor the accurate assessment of congestion for chronic patients is that simple. The current 'standard of care' involves clinical assessment, NTproBNP, and plain chest radiography—each of which constitutes a relatively insensitive assessment. This leads to underdiagnosis and high morbidity and mortality rates among acute and chronic CHF patients.
In this talk, Dr Peter Weimersheimer will explore the effectiveness of hand-held POCUS as a workflow and strategy for health systems to more accurately diagnose patients presenting with potential CHF and to monitor the effectiveness of treatment in the acute and outpatient settings.